Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Vaginal marijuana for menstrual cramps. Does it really work?

Jennifer Gunter, MD
Meds
February 11, 2016
Share
Tweet
Share

Foria wants you to know they are selling vaginal suppositories of THC (tetrahydrocannabinol) and CBD (cannabidiol) called Fiora Relief for menstrual cramps. Each suppository contains 60 mg of THC and 10 mg of CBD.

Foria claims they can treat the pain of menstrual cramps and endometriosis. Is this possible?

THC and cannabidiol (CBD) are compounds found in marijuana. The psychoactive (i.e., high) from marijuana is believed to be due to the THC, which can relax muscles and also cause euphoria and sedation as well as anxiety, paranoia, and dysphoria. Cannabidiol can stimulate receptors in the brain, reproductive, endocrine (hormone), gastrointestinal, and vascular systems. Some research suggests CBD may attenuate THC-induced tachycardia, euphoria, and anxiety (i.e. the bad parts of a high), but it’s not clear if that is really the case clinically. We have a lot to learn about these receptors and their role in pain and inflammation. Basically, we don’t know what we don’t know.

It is always hard to substantiate any claim about marijuana products due to the limited research. There is no study on THC and/or CBD for menstrual cramps or pelvic pain or endometriosis. If fact, the few studies on the reproductive tract are on rat uteri. If that doesn’t reassure you, I don’t know what will.

So what can we infer from the available research and general body of knowledge?

Oral and mucosal delivery of THC is different from smoking. Mucosal delivery (like vaginal suppositories or an oral spray) is a slower reveal to the brain than smoking. With edibles it is about 30 to 60 minutes for the drug to reach the brain.

We know a fair bit about mucosal delivery. Canada and the United Kingdom (and other countries) have the drug Sativex, a 1:1 ratio of THC and CBD to treat the muscle spasm associated with multiple sclerosis and pain from cancer. Each spray contains 2.7 mg delta-9-tetrahydrocannabinol (THC) and 2.5 mg cannabidiol (CBD). Eight sprays spread out throughout the day is very well-tolerated with no psychoactive effects.  A dose of 8 sprays over 20 minutes, so 21.6 mg, showed abuse potential. After Sativex is administered the THC and CBD appear in the bloodstream within 15 minutes. The maximum recommended dose is 12 sprays a day or 32.4 mg.

Absorption from the vaginal mucosa would likely be somewhere between the oral spray and ingestion, so between 15 and 60 minutes.

With oral administration many people consider 10 mg of THC to be one dose.

The dose of 60 mg of THC in the Fiora suppositories is significantly have higher than the recommended 32.4 mg maximum daily dose of Sativex.

It’s high doses of THC, much more common with modern strains, that takes people to the emergency department.

What about Foria’s claims?

The company says it’s product won’t get you high because “the medicine is administered as a vaginal suppository.” This makes no sense. Medications are absorbed from the vagina into the bloodstream and then from the bloodstream they go to the uterus and the brain and everywhere else that blood goes. This requires only a rudimentary knowledge of physiology. Medication doesn’t crawl up the vagina to the uterus and then just hang out avoiding circulation.

Fiora also claims the uterus has “more cannabinoid receptors than any part of the body except the brain.” I can find no study to support this assertion. Also, just because we have a receptor doesn’t mean that stimulating it produces a medicinal and safe effect. Opioids stimulate the all kinds of receptors and, of course, there is good and bad in that. Keep in mind that the role of endocannabinoid signaling in the human reproductive system is still largely not understood.

ADVERTISEMENT

What other effects could it have?

Vaginal THC and CBD could affect the vaginal ecosystem (the good bacteria).Again, untested. One study has linked marijuana use with colonization of the vagina with yeast.

Technically there is more than enough THC in Foria Relief vaginal suppositories to get you very high and even send you to the emergency department, although as vaginal absorption of THC is totally unstudied who really knows? Also, you are taking their word that this is the actual dose. The product might also contain not much of anything.

Why they decided to go with such a high dose is unknown as much lower doses can produce analgesia (pain relief), unless of course it’s not about the cramps after all.

If Foria Relief really does contain 60 mg of THC and absorption is between 15 and 60 minutes it’s hard to believe the goal isn’t to leave you paralyzed on the bed thinking menstrual cramps aren’t so bad after all.

I was going to suggest Maureen Dowd try them out and report back, but given all the unknowns and the dose I can’t recommend anyone use them. Not even for the New York Times.

Jennifer Gunter is an obstetrician-gynecologist and author of the Preemie Primer. She blogs at her self-titled site, Dr. Jen Gunter.

Image credit: Shutterstock.com

Prev

A quantitative analysis of the first year of internal medicine residency

February 11, 2016 Kevin 3
…
Next

Strategies for coping with the side effects of medications

February 11, 2016 Kevin 2
…

Tagged as: OB/GYN

Post navigation

< Previous Post
A quantitative analysis of the first year of internal medicine residency
Next Post >
Strategies for coping with the side effects of medications

ADVERTISEMENT

More by Jennifer Gunter, MD

  • The Ellen Show broadcasts potentially harmful information about ovarian cancer screening

    Jennifer Gunter, MD
  • Dear science: an appreciation

    Jennifer Gunter, MD
  • Are there too many female OB/GYNs?

    Jennifer Gunter, MD

Related Posts

  • Many questions remain about medical marijuana

    Steven Reznick, MD
  • The thorny side of medical marijuana

    Barbara Ficarra, RN, MPA
  • The problem with high-potency marijuana

    Libby Stuyt, MD
  • Qualifying conditions for medical marijuana

    Patricia Frye
  • Marijuana will not fix the opioid epidemic

    Kenneth Finn, MD
  • Doctors as the gatekeepers of marijuana is a race to the bottom

    John Schumann, MD

More in Meds

  • The diseconomics of scale: How Indian pharma’s race to scale backfires on U.S. patients

    Adwait Chafale
  • A psychiatrist’s 20-year journey with ketamine

    Muhamad Aly Rifai, MD
  • How drug companies profit by inventing diseases

    Martha Rosenberg
  • Every medication error is a system failure, not a personal flaw

    Muhammad Abdullah Khan
  • Why kratom addiction is the next public health crisis

    Muhamad Aly Rifai, MD
  • FDA delays could end vital treatment for rare disease patients

    GJ van Londen, MD
  • Most Popular

  • Past Week

    • The human case for preserving the nipple after mastectomy

      Thomas Amburn, MD | Conditions
    • Nuclear verdicts and rising costs: How inflation is reshaping medical malpractice claims

      Robert E. White, Jr. & The Doctors Company | Policy
    • How new loan caps could destroy diversity in medical education

      Caleb Andrus-Gazyeva | Policy
    • IMGs are the future of U.S. primary care

      Adam Brandon Bondoc, MD | Physician
    • Why doctors struggle with family caregiving and how to find grace [PODCAST]

      The Podcast by KevinMD | Podcast
    • When cancer costs too much: Why financial toxicity deserves a place in clinical conversations

      Yousuf Zafar, MD | Physician
  • Past 6 Months

    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • Why primary care needs better dermatology training

      Alex Siauw | Conditions
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • How a doctor defied a hurricane to save a life

      Dharam Persaud-Sharma, MD, PhD | Physician
    • What street medicine taught me about healing

      Alina Kang | Education
  • Recent Posts

    • When cancer costs too much: Why financial toxicity deserves a place in clinical conversations

      Yousuf Zafar, MD | Physician
    • Psychiatrist tests ketogenic diet for mental health benefits

      Zane Kaleem, MD | Conditions
    • The hidden rewards of a primary care career

      Jerina Gani, MD, MPH | Physician
    • Why physicians should not be their own financial planner

      Michelle Neiswender, CFP | Finance
    • Why doctors regret specialty choices in their 30s

      Jeremiah J. Whittington, MD | Physician
    • 10 hard truths about practicing medicine they don’t teach in school

      Steven Goldsmith, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 5 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The human case for preserving the nipple after mastectomy

      Thomas Amburn, MD | Conditions
    • Nuclear verdicts and rising costs: How inflation is reshaping medical malpractice claims

      Robert E. White, Jr. & The Doctors Company | Policy
    • How new loan caps could destroy diversity in medical education

      Caleb Andrus-Gazyeva | Policy
    • IMGs are the future of U.S. primary care

      Adam Brandon Bondoc, MD | Physician
    • Why doctors struggle with family caregiving and how to find grace [PODCAST]

      The Podcast by KevinMD | Podcast
    • When cancer costs too much: Why financial toxicity deserves a place in clinical conversations

      Yousuf Zafar, MD | Physician
  • Past 6 Months

    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • Why primary care needs better dermatology training

      Alex Siauw | Conditions
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • How a doctor defied a hurricane to save a life

      Dharam Persaud-Sharma, MD, PhD | Physician
    • What street medicine taught me about healing

      Alina Kang | Education
  • Recent Posts

    • When cancer costs too much: Why financial toxicity deserves a place in clinical conversations

      Yousuf Zafar, MD | Physician
    • Psychiatrist tests ketogenic diet for mental health benefits

      Zane Kaleem, MD | Conditions
    • The hidden rewards of a primary care career

      Jerina Gani, MD, MPH | Physician
    • Why physicians should not be their own financial planner

      Michelle Neiswender, CFP | Finance
    • Why doctors regret specialty choices in their 30s

      Jeremiah J. Whittington, MD | Physician
    • 10 hard truths about practicing medicine they don’t teach in school

      Steven Goldsmith, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Vaginal marijuana for menstrual cramps. Does it really work?
5 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...